Vanguard Portfolio Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$182M Sell
12,279,882
-2,109,117
-15% -$15.1M 0.01% 1222
2026
Q2
$59.9M Buy
14,388,999
+2,688,155
+23% +$10.2M ﹤0.01% 1669
2026
Q1
$41.1M Buy
+11,700,844
New +$37.4M ﹤0.01% 1717

Other funds holding IOVA

Vanguard Portfolio Management's IOVA Position: Q3 2026 in Review

Vanguard Portfolio Management reduced its Iovance Biotherapeutics (IOVA) stake by 15% in Q3 2026, selling an estimated $15.1M and leaving 12,279,882 shares worth $182M. The position accounts for 0.01% of the portfolio, ranked #1222.

Vanguard Portfolio Management first reported a position in IOVA in Q1 2026 and has held it in 3 quarters since. 335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.

  • Vanguard Portfolio Management held 12,279,882 shares of Iovance Biotherapeutics worth $182M as of Q3 2026.
  • Vanguard Portfolio Management sold 2,109,117 Iovance Biotherapeutics shares in Q3 2026, an estimated $15.1M.
  • Iovance Biotherapeutics made up 0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1222 holding.
  • Vanguard Portfolio Management first reported a position in Iovance Biotherapeutics in Q1 2026 and has held it in 3 quarters since.
  • 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.